| Crizotinib: A comprehensive review A Sahu, K Prabhash, V Noronha, A Joshi, S Desai South Asian journal of cancer 2 (2), 91, 2013 | 215 | 2013 |
| Outcome of neoadjuvant chemotherapy in “locally advanced/borderline resectable” gallbladder cancer: the need to define indications VA Chaudhari, V Ostwal, S Patkar, A Sahu, A Toshniwal, A Ramaswamy, ... HPB 20 (9), 841-847, 2018 | 79 | 2018 |
| Immune checkpoint inhibitor in first-line treatment of metastatic renal cell carcinoma: a review of current evidence and future directions I Tung, A Sahu Frontiers in oncology 11, 707214, 2021 | 49 | 2021 |
| CAPTEM in metastatic well‐differentiated intermediate to high grade neuroendocrine tumors: A single centre experience A Sahu, M Jefford, J Lai-Kwon, A Thai, RJ Hicks, M Michael Journal of Oncology 2019 (1), 9032753, 2019 | 49 | 2019 |
| Clinical outcome in definitive concurrent chemoradiation with weekly paclitaxel and carboplatin for locally advanced esophageal and junctional cancer V Noronha, K Prabhash, A Joshi, VM Patil, S Talole, D Nakti, A Sahu, ... Oncology Research 23 (4), 183, 2016 | 37 | 2016 |
| ALK positive lung cancer: clinical profile, practice and outcomes in a developing country V Noronha, A Ramaswamy, VM Patil, A Joshi, A Chougule, S Kane, ... PLoS One 11 (9), e0160752, 2016 | 35 | 2016 |
| Neoadjuvant imatinib: longer the better, need to modify risk stratification for adjuvant imatinib A Ramaswamy, D Jain, A Sahu, J Ghosh, P Prasad, K Deodhar, N Shetty, ... Journal of Gastrointestinal Oncology 7 (4), 624, 2016 | 22 | 2016 |
| Dihydro pyrimidine dehydrogenase deficiency in patients treated with capecitabine based regimens: a tertiary care centre experience A Sahu, A Ramaswamy, V Ostwal Journal of gastrointestinal oncology 7 (3), 380, 2016 | 20 | 2016 |
| Pembrolizumab induced ocular hypotony with near complete vision loss, interstitial pulmonary fibrosis and arthritis M Nguyen, MR Islam, SW Lim, A Sahu, B Tamjid Frontiers in Oncology 9, 944, 2019 | 19 | 2019 |
| Second-line palliative chemotherapy in advanced gall bladder cancer, CAP-IRI: safe and effective option A Ramaswamy, V Ostwal, N Pande, A Sahu, S Jandyal, M Ramadwar, ... Journal of gastrointestinal cancer 47, 305-312, 2016 | 18 | 2016 |
| Perioperative epirubicin, oxaliplatin, and capecitabine chemotherapy in locally advanced gastric cancer: safety and feasibility in an interim survival analysis V Ostwal, A Sahu, A Ramaswamy, B Sirohi, S Bose, V Talreja, M Goel, ... J Gastric Cancer 17 (1), 21-32, 2017 | 17 | 2017 |
| Anticancer therapy within the last 30 days of life: results of an audit and re-audit cycle from an Australian regional cancer centre M Nguyen, S Ng Ying Kin, E Shum, A Wann, B Tamjid, A Sahu, J Torres BMC palliative care 19, 1-10, 2020 | 16 | 2020 |
| Adherence to and implementation of ASCO antiemetic guidelines in routine practice in a tertiary cancer center in India VM Patil, V Noronha, A Joshi, A Ramaswamy, S Gupta, A Sahu, V Doshi, ... Journal of Oncology Practice 13 (6), e574-e581, 2017 | 14 | 2017 |
| Rectal GIST—outcomes and viewpoint from a tertiary cancer center S Zanwar, V Ostwal, A Sahu, D Jain, A Ramaswamy, A Saklani, ... Indian Journal of Gastroenterology 35, 445-449, 2016 | 13 | 2016 |
| Patterns of care and clinical outcomes in patients with metastatic renal cell carcinoma—results from a tertiary cancer center in India A Ramaswamy, A Joshi, V Noronha, VM Patil, R Kothari, A Sahu, ... Clinical Genitourinary Cancer 15 (3), e345-e355, 2017 | 12 | 2017 |
| Surgical outcomes of post chemoradiotherapy unresectable locally advanced rectal cancers improve with interim chemotherapy, is FOLFIRINOX better than CAPOX? V Ostwal, R Engineer, A Ramaswamy, A Sahu, S Zanwar, S Arya, ... Journal of Gastrointestinal Oncology 7 (6), 958, 2016 | 11 | 2016 |
| Real-world data on outcomes in metastatic castrate-resistant prostate cancer patients treated with abiraterone or enzalutamide: a regional experience R Raju, A Sahu, M Klevansky, J Torres Frontiers in Oncology 11, 656146, 2021 | 9 | 2021 |
| Role of ROR2 in promoting gastric cancer metastasis by enhancing c-JUN-mediated MMP3 transcription X Ge, F Lin, Z Wu, Y Lin, W Tang, MJ McKay, A Sahu, LS Lino-Silva, ... Annals of Translational Medicine 10 (20), 1117, 2022 | 8 | 2022 |
| Docetaxel/Oxaliplatin/Capecitabine (TEX) triplet followed by continuation monotherapy in advanced gastric cancer V Ostwal, S Bose, B Sirohi, B Poladia, A Sahu, P Bhargava, V Doshi, ... Indian Journal of Cancer 55 (1), 88-93, 2018 | 8 | 2018 |
| Efficacy and safety of sorafenib in advanced renal cell cancer and validation of Heng criteria A Joshi, A Ramaswamy, V Noronha, VM Patil, A Chandrasekharan, ... Indian Journal of Cancer 53 (3), 423-428, 2016 | 8 | 2016 |
Vanita NoronhaProfessor, Tata Memorial HospitalПотвърден имейл адрес: tmc.gov.in